Ashfield launches new meetings programme for pharmaceutical industry

The agency, which focuses on pharmaceutical industry clients, has launched the new meetings programme in response to a recent study it conducted that 95% of healthcare professionals (HCPs) expect scientific meetings to be engaging and impactful. Only 40% of respondents thought meetings they regularly attended delivered a positive experience. 

Ashfield’s new ‘Science of Meetings’ initiative is an insight-led formula that is intended to identify HCPs’ educational needs and then address them through meetings and events.

The initiative was put together by Ashfield’s Insight & Performance, Healthcare Communications and Meetings & Events teams, which deliver more than 1,700 healthcare events across more than 50 countries every year. 

Helen Hey, SVP global business development for Ashfield Healthcare Communications, said: "The new Science of Meetings approach has been introduced to all Ashfield staff across our global offices so we can clearly communicate the benefits to our pharmaceutical clients and prospects, and partner with them to make their meetings and events programmes increasingly effective in meeting HCPs’ needs."

Andrew Winterburn, global business director for Ashfield Meetings & Events, added: "This connected approach is a natural progression for our businesses and our clients. It connects our excellence to create and deliver insight-led, personalised HCP experiences.

"Key to the approach is having the strategic meeting oversight that ensures a shared vision amongst our network of experts. This approach enables us to partner with our clients to enhance insight-led, multichannel communications with HCPs across the geographies we operate in."

More:

Ashfield opens new US hub HQ in Pennsylvania

Bayer extends contract with Ashfield

Five agencies to watch in 2016: Ashfield Meetings & Events

• For more breaking news, as well as in-depth features and case studies, sign up to C&IT Magazine's daily Newstracker here